Literature DB >> 31300607

Spontaneous regression of conjunctival keratoacanthoma.

Ghada J AlBayyat1, Nandini Venkateswaran1, Dan Arreaza1, Sander R Dubovy1,2,3, Anat Galor1,4, Carol L Karp1.   

Abstract

An 83-year-old white man presented with a rapidly growing conjunctival mass in his left eye over the course of 1 month. While awaiting surgical intervention, the tumour underwent partial, spontaneous regression to half its original size. The lesion was ultimately excised with wide margins using a no-touch technique and application of cryotherapy to the corneal and conjunctival margins and scleral bed. Histopathological analysis revealed a conjunctival keratoacanthoma. To our knowledge, this is the first case documenting the partial, spontaneous regression of a conjunctival keratoacanthoma over a 5 week time course from the time of diagnosis to surgical excision. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  anterior chamber; oncology; ophthalmology; pathology

Mesh:

Year:  2019        PMID: 31300607      PMCID: PMC6626488          DOI: 10.1136/bcr-2018-228833

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  27 in total

1.  Keratoacanthoma of the conjunctiva.

Authors:  E H Hughes; L Intzedy; A D Dick; D M Tole
Journal:  Eye (Lond)       Date:  2003-08       Impact factor: 3.775

2.  Periocular keratoacanthoma: can we always rely on the clinical diagnosis?

Authors:  I Leibovitch; S C Huilgol; C L James; J D Hsuan; G Davis; D Selva
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

3.  Keratoacanthoma of the conjunctiva complicating xeroderma pigmentosum.

Authors:  R K Chowdhury; T Padhi; G S Das
Journal:  Indian J Dermatol Venereol Leprol       Date:  2005 Nov-Dec       Impact factor: 2.545

4.  Cases with a spontaneous regression of an infiltrating non-crateriform keratoacanthoma and squamous cell carcinoma with a keratoacanthoma-like component.

Authors:  Noriyuki Misago; Toshihiro Takai; Yozo Murata; Kotaro Nagase; Yutaka Narisawa
Journal:  J Dermatol       Date:  2014-03-15       Impact factor: 4.005

5.  Management of conjunctival malignant melanoma: a review and update.

Authors:  James R Wong; Afshan A Nanji; Anat Galor; Carol L Karp
Journal:  Expert Rev Ophthalmol       Date:  2014-06

6.  Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications.

Authors:  Afshan A Nanji; Christina S Moon; Anat Galor; Julia Sein; Patrick Oellers; Carol L Karp
Journal:  Ophthalmology       Date:  2014-01-09       Impact factor: 12.079

7.  [Keratoacanthoma of the bulbar conjunctiva].

Authors:  S Bellomio
Journal:  Ann Ottalmol Clin Ocul       Date:  1970-02

8.  Subconjunctival/perilesional recombinant interferon α2b for ocular surface squamous neoplasia: a 10-year review.

Authors:  Carol L Karp; Anat Galor; Sachin Chhabra; Scott D Barnes; Eduardo C Alfonso
Journal:  Ophthalmology       Date:  2010-12       Impact factor: 12.079

9.  Keratoacanthoma of the conjunctiva in a young patient.

Authors:  Gokhan Ozge; Yusuf Uysal; Osman Melih Ceylan; Onder Onguru; Fatih Mehmet Mutlu
Journal:  Arq Bras Oftalmol       Date:  2016 May-Jun       Impact factor: 0.872

Review 10.  Topical chemotherapy for ocular surface squamous neoplasia.

Authors:  Afshan A Nanji; Fouad E Sayyad; Carol L Karp
Journal:  Curr Opin Ophthalmol       Date:  2013-07       Impact factor: 3.761

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.